Tourmaline Bio
Nicholas Yang is a Senior Associate at Tourmaline Bio with previous experience as an Analyst at Roivant Sciences. Nicholas has a strong background in research, particularly in the field of chimeric antigen receptor (CAR) T cell therapy, and has worked on various projects to enhance the efficacy of cancer treatments. Nicholas holds a Bachelor's degree in Economics, Finance, and Behavioral Economics, as well as a Bachelor's degree in Biology.
This person is not in any teams
Tourmaline Bio
2 followers
Tourmaline is a late-stage clinical biotechnology company driven by our mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune and inflammatory diseases. In doing so, we seek to develop assets medicines that have the potential to establish new standards-of-care in areas of high unmet medical need.